Parallel Mapping for Ventricular Tachycardia

Status Completed

Clinical Trial Summary

Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.

Clinical Trial Description

In patients with scar in the hearts after heart attacks, the risk for dangerous abnormal heart rhythms, including sudden death is high. This is because dead muscle fibers are replaced by scar tissue, creating a physiological condition promoting abnormal heart rhythms.These abnormal heart rhythms are called ventricular arrhythmias or ventricular tachycardias. In these patients, ablation procedures can be helpful, however the recurrence rate of arrhythmias after ablation remains unacceptably high. The primary reason for this high recurrence rate is nonspecific mapping methodologies for identifying the heart area responsible for these arrhythmias. Therefore, new methods for increasing the specificity of mapping have been the subject of significant research for many years, however implementation of these methods in clinical practice has been challenged by limited technologies. Recently, a new mapping technology named "parallel mapping" has been developed, received FDA approval and is routinely utilized at the Cleveland Clinic. However, the workflow of using parallel mapping, and the efficacy of ablation using this technology have not been evaluated. ;

Study Design

Related Conditions & MeSH terms

Arrythmia
Implantable Cardioverter Defibrillator (ICD)
Tachycardia
Tachycardia, Ventricular
Ventricular Tachycardia (V-Tach)

Clinical Trial Details

NCT number	NCT04477499
Study type	Observational
Source	The Cleveland Clinic
Contact
Status	Completed
Phase
Start date	July 15, 2020
Completion date	December 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00376532` - Extracellular Matrix Marker of Arrhythmia Risk (EMMA)	N/A
Recruiting	`NCT04848844` - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Completed	`NCT06039397` - The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure	N/A
Completed	`NCT04025762` - 24/7 Closed-loop in Older Subjects With Type 1 Diabetes	N/A
Not yet recruiting	`NCT03619018` - All Inclusive KODEX - EPD™ Study Patient Specific Optimized Therapy (PSOT) Study
Completed	`NCT03786640` - Abbott Brady 3T MRI PMCF
Recruiting	`NCT05935007` - Aveir DR Real-World Evidence Post-Approval Study
Recruiting	`NCT05932602` - AVEIR DR Coverage With Evidence Development (CED) Study
Recruiting	`NCT01988064` - Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases.	N/A
Recruiting	`NCT06310707` - Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter	N/A
Terminated	`NCT03481413` - Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Recruiting	`NCT05443321` - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes	N/A
Recruiting	`NCT03801681` - ARrhythmias in MYocarditis
Completed	`NCT03628534` - SERF VT Ablation Early Feasibility Study (EFS)	N/A
Recruiting	`NCT05034432` - The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4
Recruiting	`NCT04856267` - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Completed	`NCT02401659` - Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems	N/A
Recruiting	`NCT05790642` - Comparison of Different Non-invasive Methods to Assess Pulse Wave Analysis
Recruiting	`NCT04833712` - Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation	N/A
Not yet recruiting	`NCT06371937` - iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease